Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control
Nutrients · 15.08.2025 · 17 (16) · 2653
DOI: 10.3390/nu17162653 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 15.08.2025. Verfasst von Giovanni Sartore und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy. Hauptthemen laut MEDLINE: Chlorophyll, Diabetes Mellitus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Chlorophyll, the green pigment essential for photosynthesis, abundantly found in green vegetables and algae, has attracted growing scientific interest for its potential therapeutic effects, particularly in diabetes management. Recent research highlighted that chlorophyll and its derivatives may beneficially influence glucose metabolism and oxidative stress, key factors in diabetes. This review examines current knowledge on how chlorophyll compounds could aid diabetes control. Chlorophyll and its derivatives appear to support glucose regulation primarily through actions in the gastrointestinal tract. They modulate gut microbiota, improve glucose tolerance, reduce inflammation, and alleviate obesity-related markers. While chlorophyll itself does not directly inhibit digestive enzymes like α-glucosidase, its derivatives such as pheophorbide a, pheophytin a, and pyropheophytin a may slow carbohydrate digestion, acting as α-amylase and α-glucosidase inhibitors, reducing postprandial glucose spikes. Additionally, chlorophyll enhances resistant starch content, further controlling glucose absorption. Beyond digestion, chlorophyll derivatives show promise in inhibiting glycation processes, improving insulin sensitivity through nuclear receptor modulation, and lowering oxidative stress. However, some compounds pose risks due to photosensitizing effects and toxicity, warranting careful consideration. Chlorophyllin, a stable semi-synthetic derivative, also shows potential in improving glucose and lipid metabolism. Notably, pheophorbide a demonstrates insulin-mimetic activity by stimulating glucose uptake via glucose transporters, offering a novel therapeutic avenue. Overall, the antioxidant, anti-inflammatory, and insulin-mimicking properties of chlorophyll derivatives suggest a multifaceted approach to diabetes management. While promising, these findings require further clinical validation to establish effective therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine-DIMED, University of Padova, 35128 Padova, Italy.
- Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.
- Studium Patavinum, University of Padova, 35122 Padova, Italy.
ORCID-Profile: Giovanni Sartore, Giuseppe Zagotto, Eugenio Ragazzi
Zitieren
APA
Sartore, G., Zagotto, G., & Ragazzi, E. (2025). Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control. Nutrients, 17(16), 2653. https://doi.org/10.3390/nu17162653
Vancouver
Sartore G, Zagotto G, Ragazzi E. Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control. Nutrients. 2025;17(16):2653. doi:10.3390/nu17162653
BibTeX
@article{Sartore2025,
author = {Sartore, Giovanni and Zagotto, Giuseppe and Ragazzi, Eugenio},
title = {Beyond Green: The Therapeutic Potential of Chlorophyll and Its Derivatives in Diabetes Control},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {16},
pages = {2653},
doi = {10.3390/nu17162653}
}
EUVIMED